46415-29-6 Usage
General Description
1-(4-Ethoxyphenyl)piperazine, also known as 4-EtO-PIP, is a psychoactive compound that belongs to the class of piperazine derivatives. It is commonly used as a research chemical and has been studied for its potential therapeutic effects on conditions such as anxiety and depression. 4-EtO-PIP has also been investigated for its potential use in the treatment of substance abuse disorders. It acts as a selective serotonin receptor agonist, meaning it interacts with the serotonin receptors in the brain, potentially affecting mood and behavior. However, its safety and efficacy for human use have not been fully established, and caution should be exercised when handling and researching this chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 46415-29-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,6,4,1 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 46415-29:
(7*4)+(6*6)+(5*4)+(4*1)+(3*5)+(2*2)+(1*9)=116
116 % 10 = 6
So 46415-29-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H18N2O/c1-2-15-12-5-3-11(4-6-12)14-9-7-13-8-10-14/h3-6,13H,2,7-10H2,1H3
46415-29-6Relevant articles and documents
Potent, selective, and orally active adenosine A2A receptor antagonists: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
Neustadt, Bernard R.,Hao, Jinsong,Lindo, Neil,Greenlee, William J.,Stamford, Andrew W.,Tulshian, Deen,Ongini, Ennio,Hunter, John,Monopoli, Angela,Bertorelli, Rosalia,Foster, Carolyn,Arik, Leyla,Lachowicz, Jean,Ng, Kwokei,Feng, Kung-I
, p. 1376 - 1380 (2008/02/05)
Antagonism of the adenosine A2A receptor offers great promise in the treatment of Parkinson's disease. Employing the known pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine A2A antagonist SCH 58261 as a starting point, we identified the potent and selective (vs. A1) antagonist 11 h, orally active in the rat haloperidol-induced catalepsy model. We further optimized this lead to the methoxyethoxyethyl ether 12a (SCH 420814), which shows broad selectivity, good pharmacokinetic properties, and excellent in vivo activity.